Summit Therapeutics Inc.SMMTNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 59.03% |
| Q2 2025 | -799.19% |
| Q1 2025 | -2.79% |
| Q4 2024 | -8.80% |
| Q3 2024 | 6.84% |
| Q2 2024 | -38.90% |
| Q1 2024 | -51.56% |
| Q4 2023 | -34.87% |
| Q3 2023 | -44.51% |
| Q2 2023 | 97.29% |
| Q1 2023 | -2720.61% |
| Q4 2022 | 10.08% |
| Q3 2022 | -27.51% |
| Q2 2022 | 21.62% |
| Q1 2022 | 16.86% |
| Q4 2021 | -31.31% |
| Q3 2021 | 19.73% |
| Q2 2021 | -39.62% |
| Q1 2021 | -28.49% |
| Q4 2020 | 23.11% |
| Q3 2020 | -16.22% |
| Q2 2020 | -148.30% |
| Q1 2020 | 11.06% |
| Q4 2019 | 23.95% |
| Q4 2019 | -44.55% |
| Q3 2019 | -20.54% |
| Q2 2019 | 13.91% |
| Q1 2019 | 41.51% |
| Q4 2018 | -129.55% |
| Q3 2018 | 534.88% |
| Q2 2018 | 49.38% |
| Q1 2018 | -1737.11% |
| Q4 2017 | 79.94% |
| Q3 2017 | 29.95% |
| Q2 2017 | 7.15% |
| Q1 2017 | -18.50% |
| Q4 2016 | 31.84% |
| Q3 2016 | -7.18% |
| Q2 2016 | -56.24% |
| Q1 2016 | 31.83% |